Sparrow Pharmaceuticals, Inc.

New Filing
CIK: 0001786949·Pharmaceuticals·DELAWARE·Filed: Apr 12, 2024
Total Offering

$15,251,730

Amount Sold

$10,000,000

Investors

4

First Sale

Apr 10, 2024

Offering Details

Type
Debt, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Robert Jacks
Related Person
Niall O'Donnell
Related Person
Jonathan Root
Related Person
Peter Thompson
Related Person
Klaus Veitinger
Related Person

Company

Sparrow Pharmaceuticals, Inc.

1050 Southwest 6th Street, Suite 1100

PORTLAND, OR, 97204

617-465-0328

SEC Filing

0001786949-24-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Sparrow Pharmaceuticals, Inc. Form D Filing — $15,251,730 | FilingFlow